Autoimmune polyglandular syndrome among Chinese celiac disease patients: a survey of 243 individuals in China
- PMID: 40698092
- PMCID: PMC12279860
- DOI: 10.3389/fimmu.2025.1606237
Autoimmune polyglandular syndrome among Chinese celiac disease patients: a survey of 243 individuals in China
Abstract
Background: Celiac disease (CeD), an autoimmune enteropathy, is often associated with multiple glandular autoimmune diseases. However, the prevalence and staging characteristics of autoimmune polyglandular syndrome (APS) among CeD patients remain unclear. The aim of this study was to assess the prevalence and clinical features of APS among Chinese CeD patients.
Methods: Clinical data and medical records of 243 CeD patients diagnosed in northwest China were retrospectively analyzed to identify comorbid autoimmune diseases among CeD patients. Serum interferon-ω1, interferon-α, and thyroid autoantibodies (TPOAb and TgAb) were measured, and AIRE mutations were detected. APS typing was conducted based on serum antibodies, gene sequencing (AIRE mutation analysis), and comorbidity analysis.
Results: The overall prevalence of APS in CeD patients was 10.3% (25/243), and the prevalence of different types of APS varied as follows: APS-1: 0.4%, APS-2: 0.4%, APS-3: 8.2%, and APS-4: 1.2%. The prevalence of APS in CeD patients was significantly higher than that in the general population, especially the prevalence of APS-3. Patients with CeD combined with APS had a higher prevalence of vitamin D deficiency (13 of 25 patients, 52%) and H. pylori infection (8 of 25 patients, 32%). In addition, CeD patients with combined APS were more likely to have anxiety and depressive symptoms (P < 0.05), but there were no significants differences in gender, ethnicity, or body mass index.
Conclusion: This study is the first to systematically evaluate the prevalence and staging characteristics of APS among CeD patients, thereby filling the epidemiological data gap in this area. We emphasize the significance of screening for APS among CeD patients to enable early detection and treatment of associated autoimmune diseases and enhance patients' quality of life.
Keywords: autoimmune polyglandular syndromes; autoimmune thyroid disease; celiac disease; epidemiology; glandular autoimmunity.
Copyright © 2025 Xue, Feng, Shi, Halike, Maimaitireyimu, Abudurexiti, Xie, Yao and Gao.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Screening and Analysis of the Clinical Characteristics of Celiac Disease Autoimmunity in the Young Population in Northwest China.J Dig Dis. 2025 Mar-Apr;26(3-4):143-149. doi: 10.1111/1751-2980.13351. Epub 2025 Jun 12. J Dig Dis. 2025. PMID: 40509574
-
Clinical and serological characteristics of type 3 APS, isolated T1DM and LADY/LADA.BMC Endocr Disord. 2025 Jul 1;25(1):155. doi: 10.1186/s12902-025-01969-2. BMC Endocr Disord. 2025. PMID: 40597940 Free PMC article.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Home treatment for mental health problems: a systematic review.Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150. Health Technol Assess. 2001. PMID: 11532236
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Jan 9;1:CD011535. doi: 10.1002/14651858.CD011535.pub3. PMID: 29271481 Free PMC article. Updated.
References
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous